- 8
- 2
- 1
Michel Boisbrun
Maître de Conférences HDR, Université de Lorraine
Enseignement : Faculté de Parmacie
Recherche : Laboratoire Lorraine de Chimie Moléculaire (L2CM), UMR CNRS 7053
11
Documents
Affiliations actuelles
- 527642
Identifiants chercheurs
- michel-boisbrun
- 0000-0001-6588-0027
- IdRef : 087260093
Présentation
Maître de Conférences HDR
Laboratoire Lorrain de Chimie Moléculaire (L2CM) UMR CNRS 7053
Université de Lorraine
Publications
- 2
- 1
- 1
- 3
- 2
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 11
- 11
- 10
- 6
- 5
- 4
- 4
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
Corrigendum to “New desulfured troglitazone derivatives: Improved synthesis and biological evaluation” [Eur. J. Med. Chem. 187 (2020) 111939]European Journal of Medicinal Chemistry, 2020, 208, pp.112834. ⟨10.1016/j.ejmech.2020.112834⟩
Article dans une revue
hal-03503731v1
|
|
|
New desulfured troglitazone derivatives: Improved synthesis and biological evaluationEuropean Journal of Medicinal Chemistry, 2020, 187, pp.111939. ⟨10.1016/j.ejmech.2019.111939⟩
Article dans une revue
hal-02421051v1
|
Pro-apoptotic effect of Δ2-TGZ in "claudin-1-low" triple-negative breast cancer cells: involvement of claudin-1Breast Cancer Research and Treatment, 2017, 165 (3), pp.517-527. ⟨10.1007/s10549-017-4378-2⟩
Article dans une revue
hal-01589665v1
|
|
Δ2-Troglitazone promotes cytostatic rather than pro-apoptotic effects in breast cancer cells cultured in high serum conditionsCell Cycle, 2016, 15 (24), pp.3402-3412. ⟨10.1080/15384101.2016.1245248⟩
Article dans une revue
hal-01411104v1
|
D2-Troglitazone alters energetic metabolism in triple-negative breast cancer cells: a mechanism to sensitize cancer cells to chemotherapy?Poster de conférence hal-01214915v1 |
|
Delta-2-troglitazone sensitizez triple-negative breast cancer cells to chemotherapy: a consequence of mitochondrial dysfunction?6th World Congress on Targeting Mitochondria, Oct 2015, Berlin, Germany. 2015
Poster de conférence
hal-01214922v1
|